Marijuana and glaucoma

Archives of Ophthalmology

Volumn 116, Issue 11, 1998, Pages 1512-1513

  Kaufman, Paul L ^a  

^a Department of Ophthalmology Science ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN HYDROGEN TARTRATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRIMONIDINE; CANNABINOID; CANNABIS; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIPIVEFRINE; PILOCARPINE; PROSTAGLANDIN F2 ALPHA DERIVATIVE; TIMOLOL;

ANIMAL MODEL; CILIARY BODY EPITHELIUM; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; GLAUCOMA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAOCULAR PRESSURE; NERVE CELL; NERVE DEGENERATION; OPTIC NERVE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION;

EID: 0031772988     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.116.11.1512     Document Type: Editorial

References (1)

1. Green K. Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol. 1998;116:1433-1437.